Orasure Technologies, Inc
A maker of rapid point-of-care tests, OraSure Technologies is best known for the OraQuick HIV test that runs on a simple oral swab, along with tests for COVID-19, hepatitis C, syphilis, and sickle cell, plus sample-collection kits like Oragene and Colli-Pee used in clinics and at home. The company took its current form in 2000 when Epitope and STC Technologies merged, and its name blends "oral" (for its non-invasive mouth-based testing) with "sure." A fun twist: its Oragene saliva kits helped kick off the era of mail-order DNA testing from a simple spit sample.
Granted 484.5K · Bought 54.3K
Granted 115.2K · Bought 54.3K
Granted 62.5K
Granted 57.2K
Granted 46.1K · Bought 2.1K
Granted 89.7K · Bought 75.0K
Granted 46.1K
Granted 46.1K
Granted 79.8K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Eglinton Manner CarriePresident & CEO, Director · 6 transactions | +19.7% | 2.19M | 484.5K | 54.3K | — |
| McGrath Kenneth JChief Financial Officer · 6 transactions | +31.5% | 589.6K | 115.2K | 54.3K | — |
| Kenny John P.Director · 3 transactions | +42.5% | 209.7K | 62.5K | — | — |
| Anthony Michele MarieSVP Finance & CAO · 4 transactions | +25.1% | 185.8K | 57.2K | — | — |
| Gagliano Nancy JDirector · 3 transactions | +17% | 185.1K | 46.1K | 2.1K | — |
| Boyd Steven KyleDirector · 8 transactions | — | 163.2K | 89.7K | 75.0K | — |
| Marmora LelioDirector · 2 transactions | +13.5% | 148.5K | 46.1K | — | — |
| McMahon Robert W.Director · 2 transactions | +23.2% | 123.1K | 46.1K | — | — |
| Bertrand John D.Director · 2 transactions | — | 79.8K | 79.8K | — | — |
Select a row to see that insider’s individual transactions.
Net open-market activity over the last year: +185.7K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.